EsoCap AG has been selected to be featured in GoingPublic Magazine, a major German magazine for corporate finance and investment topics.
“We are very pleased to be featured in GoingPublic Magazine as a company that is at the forefront of providing drugdiscovery and development solutions and transforming businesses,” said Isabelle Racamier, CEO of EsoCap AG, “This recognition reinforces our determination to make a difference in patients’ lives through EsoCap’s promising and innovative technology.”
Read Online Article at GoingPublic.de
